According to Ding W. et al., sAPRIL demonstrated significant diagnostic utility (AUC = 0.854) at a cut-off point of 5.49 ng/mL, outperforming currently utilized tumor markers (CEA and CA 19-9). Here, CEACAM5 is linked to neoplasm.